# AHD-RESEARCH-001 — Research Status (UPDATED 24/04/2026)
**Avina Home Detox LLC**
**Status:** ALL 5 SEATS LANDED — synthesis complete
**Started / Completed:** 24/04/2026

---

## Status: COMPLETE

All 5 NEXUS swarm seats have returned. Total research time: ~5-9 minutes per seat in parallel. Token cost: ~$3-5 USD across all seats vs ~$50-200 if attempted inline on Opus.

| Seat | Topic | Status | Key Finding |
|---|---|:---:|---|
| 01 | NAD IV clinical evidence | LANDED | No RCTs in AUD/OUD; pilot data only; specific defensible vs avoid claims defined |
| 02 | Concierge IV competitive landscape | LANDED | White space confirmed; AHD position is unoccupied; pricing benchmarks verified |
| 03 | In-home IV regulatory map CA/NY/FL | LANDED | **5 critical landmines identified including AB5, HHA licensure, controlled substance chain of custody** |
| 04 | Combined detox + IV protocol design | LANDED | 8-protocol IV library v1.0 with evidence grades; replaces v0.1 placeholder |
| 05 | UHNW concierge wellness brand teardown | LANDED | 3 brand directions for AHD; Swiss transparency vs opacity model analysis; voice cues |

---

## Where to Read

**The synthesis:** [AHD-RESEARCH-SYNTHESIS-v1.0.md](AHD-RESEARCH-SYNTHESIS-v1.0.md) — the boardroom-ready synthesis of all 5 returns with action items per finding.

**Critical headlines from the synthesis:**

1. **CA AB5 likely makes the 1099 nurse model illegal.** Cost basis shifts.
2. **HHA licensure required in all 3 states.** Adds $30K + 60-120 days per state.
3. **NAD has no RCT evidence.** Marketing claims must be carefully scoped.
4. **White space is confirmed.** No US competitor sits at AHD's exact intersection.
5. **CA-only Y1 launch is the correct strategy** given the regulatory stack.

---

## Documents that need v0.2 update based on the findings

- AHD-CAPITAL-PLAN-v0.1 → v1.0 (cost basis revision)
- AHD-REGULATORY-MAP-v0.1 → v1.0 (replace placeholder with 5-landmine framework)
- AHD-IV-LIBRARY-v0.1 → v1.0 (8 evidence-graded protocols)
- AHD-BRAND-DIRECTION-v0.1 → v1.0 (3 brand directions)
- AHD-OPERATING-MANUAL-v0.1 (controlled-substance handling section)
- AHD-NURSING-CURRICULUM-v0.1 (Module 07 IV Library reference)
- Marketing site (site/index.html) — NAD claims + brand voice
- AHD-COUNSEL-SHORTLIST briefing — expanded scope for Nelson Hardiman

These updates are queued. The synthesis document captures all the changes in one place; individual document updates can be sequenced based on what Fabian wants to walk first.

---

*Status: ALL LANDED · Synthesis complete · Awaiting Fabian's decision on the 5 forced decisions in the synthesis (nurse classification, capital revision, brand direction, NAD claims discipline, multi-state strategy).*